Niagen Bioscience (NAGE) Change in Account Payables (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Change in Account Payables data on file, last reported at $2.5 million in Q1 2026.

• On a quarterly basis, Change in Account Payables rose 17.81% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 21.56% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, up 312.75% from the prior year.
• Change in Account Payables for Q1 2026 stood at $2.5 million, up from -$1.9 million in the prior quarter.
• Over the last five years, Change in Account Payables for NAGE reached as high as $3.0 million in Q2 2025 and fell as low as -$2.3 million in Q1 2024.
• Historically, Change in Account Payables has averaged $205470.6 across 5 years, with a median of $206000.0 in 2024.
• Across the five-year window, Change in Account Payables sank 229.26% in 2022 and jumped 1379.61% in 2025, its largest moves.
• Year by year, Change in Account Payables stood at $560000.0 in 2022, then jumped by 84.64% to $1.0 million in 2023, then surged by 118.76% to $2.3 million in 2024, then sank by 186.03% to -$1.9 million in 2025, then jumped by 227.49% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were $2.5 million in Q1 2026, -$1.9 million in Q4 2025, and -$938000.0 in Q3 2025.